FDA Clearance Tracker · K211079
BioFire COVID-19 Test 2
Last checked: Nov 20, 2026Latest source record: Nov 1, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Nov 1, 2021
Substantially Equivalent
Time to decision
203 days
Received Apr 12, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K211079
- Device name
- BioFire COVID-19 Test 2
- Applicant
- Biofire Defense, LLC
- Applicant location
- Salt Lake City, UT
- Received
- Apr 12, 2021
- Decided
- Nov 1, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3981
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QQX (Respiratory Specimen Nucleic Acid Sars-Cov-2 Test).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K211079
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Biofire Defense, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262842 · Decided Nov 4, 2026 · 84 days after receipt
Device type: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays (PMN) · Laboratory Medicine & Pathology
K261475 · Decided Jul 17, 2026 · 73 days after receipt
Device type: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays (PMN) · Laboratory Medicine & Pathology
K243822 · Decided Mar 12, 2025 · 90 days after receipt
Device type: Product code (PRD) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.